Institute of Human Virology
  • Institute of Human Virology Announces New Leadership Appointments

    Please join us in congratulating Drs. Charurat, Chua, Rosenthal, and Sajadi as they assume their new leadership roles, and in thanking Dr. Kottilil for his years of dedicated service and leadership at IHV.

    READ MORE
  • Vile labeled HIV next to the HIV virus seen in a microscope

    New Study Identifies Key Mechanism Driving HIV-Associated Immune Suppression

    Learn More
  • Jacques Initiative's Test & Treat Partnership Awarded

    The award was accepted on behalf of JACQUES Initiative (JI) by Shakima Davey, LCSW-C, Program Director at JI, the community health outreach and engagement program of the Institute of Human Virology (IHV) at the University of Maryland School of Medicine.

    LEARN MORE
  • Institute of Human Virology Announces New Leadership Appointments

    Please join us in congratulating Drs. Charurat, Chua, Rosenthal, and Sajadi as they assume their new leadership roles, and in thanking Dr. Kottilil for his years of dedicated service and leadership at IHV.

    READ MORE
  • IHV Researchers Publish Study in Oncogene Uncovering New Insights into Colorectal Cancer Metastasis

    Yan Liu, PhD, Assistant Professor, advance our understanding of how colorectal cancer spreads and identify a promising therapeutic target for preventing metastasis.

    READ MORE
Institute of Human Virology (IHV)

SUPPORT IHV

X  Facebook round logo YouTube round logo

Research Initiatives

IHV Building‌IHV Research is Leading the Way Toward Innovative Therapies

IHV scientists and researchers are forging new paths in the fight against HIV and AIDS, the deadliest pandemic in modern medical history. The IHV is the first research institute in the U.S. to link basic science, population studies and clinical trials in an effort to develop new vaccines and treatments.

IHV Research


Patient Information

Doctor helping patientIHV is Providing Compassionate Cutting-Edge Care

The IHV serves approximately 5,000 patients through six Baltimore area clinics and more than 500,000 patients in seven African and two Caribbean nations. The IHV specializes in the treatment of HIV/AIDS and other chronic viral diseases, such as Hepatitis C, Hepatitis B, and the Human Papilloma Virus Infection.

IHV Clinical Care